White label ELPA - ClinicalTrials.eu

A Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection

Not recruiting

3 1 1
Investigated Drugs:
- Bjt-778
A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

Not recruiting

2 1
Investigated Drugs:
- HUMAN IGG1 BISPECIFIC MONOCLONAL ANTIBODY AGAINST KALLIKREIN-5 AND KALLIKREIN-7
A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

Not recruiting

3 1 1
Investigated Diseases:
- Hormone-dependent prostate cancer
- Prostate cancer metastatic
Investigated Drugs:
- 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
- Enzalutamide
+6
A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome

Not recruiting

2 1 1
Investigated Drugs:
A study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes

Not recruiting

2 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
- ALN-4324
Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

Not recruiting

3 1 1
Investigated Drugs:
+1
Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

Not recruiting

2 1 1 1
Investigated Diseases:
- Warm autoimmune haemolytic anaemia
- Immune thrombocytopenia
Investigated Drugs:
+3
A Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness

Not recruiting

4 1 1
Investigated Drugs:
- Raludotatug Deruxtecan
A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

Not recruiting

2 1 1
Investigated Drugs:
- Leniolisib Phosphate
A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

Not recruiting

2 1 1 1
Investigated Drugs:
- Ocrelizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies